Caris Life Sciences Stock Alpha and Beta Analysis

CAI Stock  USD 26.40  0.80  3.12%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Caris Life Sciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Caris Life over a specified time horizon. Remember, high Caris Life's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Caris Life's market risk premium analysis include:
Beta
0.42
Alpha
(0.25)
Risk
3.59
Sharpe Ratio
(0.06)
Expected Return
(0.22)
Please note that although Caris Life alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Caris Life did 0.25  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Caris Life Sciences stock's relative risk over its benchmark. Caris Life Sciences has a beta of 0.42  . As returns on the market increase, Caris Life's returns are expected to increase less than the market. However, during the bear market, the loss of holding Caris Life is expected to be smaller as well. The Caris Life's current Book Value Per Share is estimated to increase to -8.39. The Caris Life's current Tangible Book Value Per Share is estimated to increase to -8.45.
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Caris Life Backtesting, Caris Life Valuation, Caris Life Correlation, Caris Life Hype Analysis, Caris Life Volatility, Caris Life History and analyze Caris Life Performance.

Caris Life Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Caris Life market risk premium is the additional return an investor will receive from holding Caris Life long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Caris Life. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Caris Life's performance over market.
α-0.25   β0.42

Caris Life expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Caris Life's Buy-and-hold return. Our buy-and-hold chart shows how Caris Life performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Caris Life Market Price Analysis

Market price analysis indicators help investors to evaluate how Caris Life stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Caris Life shares will generate the highest return on investment. By understating and applying Caris Life stock market price indicators, traders can identify Caris Life position entry and exit signals to maximize returns.

Caris Life Return and Market Media

The median price of Caris Life for the period between Fri, Oct 17, 2025 and Thu, Jan 15, 2026 is 27.94 with a coefficient of variation of 8.67. The daily time series for the period is distributed with a sample standard deviation of 2.41, arithmetic mean of 27.77, and mean deviation of 2.01. The Stock received a lot of media exposure during the period.
 Price Growth (%)  
       Timeline  
1
What To Expect From Caris Life Sciences Inc Q3 2025 Earnings
11/04/2025
2
Caris Precision Oncology Alliance Fellows Forum Welcomes 20252026 Class
11/21/2025
3
Caris Life Sciences to Showcase 19 Studies at the 2025 San Antonio Breast Cancer Symposium
12/04/2025
4
Acquisition by Denton John Russel of 4184 shares of Caris Life at 24.09 subject to Rule 16b-3
12/05/2025
5
Can Caris Life Sciences,Inc. Climb 32.81 percent to Reach the Level Wall Street Analysts Expect
12/08/2025
6
Disposition of 650 shares by Brille Brian J of Caris Life subject to Rule 16b-3
12/10/2025
7
Cannaccord Genuity Asserts Hold Stance on Caris Life Sciences, Inc. On Oncology Pipeline Development
12/11/2025
8
Caris Life Sciences Rethinking Valuation After a Recent Share Price Rebound
12/17/2025
9
Disposition of 10000 shares by Gary Sawka of Caris Life at 5.6 subject to Rule 16b-3
12/19/2025
10
Caris Life Sciences Stronger Fundamentals, Same Conclusion - Seeking Alpha
12/24/2025
11
12 Health Care Stocks Moving In Tuesdays After-Market Session - Benzinga
01/06/2026
12
Disposition of 2500 shares by Castleman Peter M of Caris Life at 18.6 subject to Rule 16b-3
01/09/2026
13
Caris Life Sciences Partners with Everlywell to Launch Caris Forthcoming MCED Assay, Caris Detect
01/12/2026
14
A Look At Caris Life Sciences Valuation After The Everlywell Caris Detect Partnership And 2025 Outlook
01/13/2026

About Caris Life Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Caris or other stocks. Alpha measures the amount that position in Caris Life Sciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2025 2026 (projected)
Dividend Yield0.03170.0333
Price To Sales Ratio15.5716.34

Caris Life Investors Sentiment

The influence of Caris Life's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Caris. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Caris Life's public news can be used to forecast risks associated with an investment in Caris. The trend in average sentiment can be used to explain how an investor holding Caris can time the market purely based on public headlines and social activities around Caris Life Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Caris Life's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Caris Life's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Caris Life's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Caris Life.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Caris Life in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Caris Life's short interest history, or implied volatility extrapolated from Caris Life options trading.

Build Portfolio with Caris Life

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Caris Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Caris Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Caris Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Caris Life Sciences Stock:
Caris Life technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Caris Life technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Caris Life trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...